Peter Altman - 19 Sep 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Reporting relationship: President and CEO, Director
Issuer ticker: BCDA
Reported as of: 19 Sep 2025
Net transaction value: +$60,000
SEC form: 4
Accepted by SEC: 23 Sep 2025, 09:00:09 UTC
Prior SEC filing: 25 Aug 2025
Next SEC filing: 10 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ David McClung, by power of attorney

Key filing fact

Peter Altman filed Form 4 for BioCardia, Inc. (BCDA) on 23 Sep 2025.

Key facts

This page summarizes Peter Altman's Form 4 filing for BioCardia, Inc. (BCDA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Sep 2025, 09:00.

Change

Previous filing in this sequence was filed on 25 Aug 2025.
Current net transaction value: +$60,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647542 Primary reporting owner

Altman Peter

Relationship: President and CEO, Director
Address: C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE
Signature: /s/ David McClung, by power of attorney
Signature date: 23 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCDA transaction

Common Stock

Purchase

Transaction value: $60,000
Shares: +48,000
Change %: +28%
Price: $1.25
Shares after: 216,762
Date: 19 Sep 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCDA transaction Derivative

Warrant (right to buy)

Purchase

Transaction value
Shares: +48,000
Change %: +50%
Price
Shares after: 143,612
Date: 19 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 48,000
Exercise price: $1.25
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.